Tala El Tal, MD, Msc

Pediatric Rheumatologist | MSc in QIPS @UofT | SickKids & AUB Alumni | Musician | Aspiring Baker

[The Journal of Rheumatology @jrheum]

Research Article

Evaluation of a Pediatric-Adult Dyad Care Model for Transitioning Youth With Childhood-Onset Systemic Lupus Erythematosus

📖 https://t.co/tPQuo3hk46
@TalPedsRheum @SickKidsNews

#Pediatric #Lupus

[Mithu Maheswaranathan, MD @MithuRheum]

🆕 ACR 2025 Guidelines for Treatment of Systemic Lupus Erythematosus

#ACR25 #Lupus #RheumTwitter

[Tala El Tal, MD, Msc @TalPedsRheum]

Fantastic talk by Dr Laurent Arnaud @Lupusreference on the complexities of SLE diagnosis and management insightful, evidence-based, and clinically relevant

[Zahi Touma, MD, PhD @ZahiTouma]

Toronto Lupus Program 🦋
📢Congrats on your work Drs. Joy Feld & Oshrat Tayer-Shifman

✅Check our recent publication on Primary Headache in SLE – systematic review & meta-analysis
🟪All you need to know about Headaches in SLE

https://t.co/uQgk7g94sm
@uoftmedicine

[Lupus Europe @LupusEurope]

🚨Today is #WorldMentalHealthDay.

☝️Do you know that #lupus patients are at high risk of anxiety and #depression?

Always talk to your physician about how you feel. Addressing mental health problems promptly is key.

🦋 Know more. Visit #LupusGPT

https://t.co/AolALvG1LC

[Lupus Europe @LupusEurope]

🦋It's #LupusAwarenessMonth❗

🦵 #KickLupus:  make it visible

Take part in the Living With Lupus in 2024 survey.

🗣️Your insights are crucial for capturing the diverse experiences of those living with #lupus across Europe.

🧵Find the link for all 21 languages in this thread⤵️

[Bobbi Berard @BobbiBerard]

We are honored to have received this award and are so excited for this work to get underway with our awesome team @knightandrea91 @m_batthish @kabeattie @SholdiceMatthew @CdnANetwork @SchulichMedDent @Karen Bax @ Sarah Wells @Cassie and Friends Hamilton @Cassie and Friends London

[Tala El Tal, MD, Msc @TalPedsRheum]

@BobbiBerard @knightandrea91 @m_batthish @kabeattie @SholdiceMatthew @CdnANetwork @SchulichMedDent @Karen @Cassie Congratulations! Wonderful!

[Janet Pope @Janetbirdope]

Lupus patients will die from

PREVENTABLE cancer of the cervix if

We don’t vaccinate against HPV
We don’t screen with PAP tests

STUDY SHOWS 1|2 of women with #SLE are not screened over 5 years

Paps are needed at recommended rates

@CRASCRRheum #AGM24

[Tala El Tal, MD, Msc @TalPedsRheum]

@MDushnicky A rheumatology star 😍

[Andrea Fava @andreafava]

🔬 Exciting news in #Lupus! Our latest study is out. Discover how urinary biomarkers can transform lupus nephritis diagnosis & guide treatment. Plus novel insights into disease mechanism 🚀🚀. Dive into the research here https://t.co/mLVf94Fwye #Rheumatology #Nephrology

[Tala El Tal, MD, Msc @TalPedsRheum]

@ZahiTouma @UHN @MUrowitz @SchroederInst Congratulations! Well deserved!

[Alène Toulany @DrAleneToulany]

My research lab just dropped a phenomenal video on youth engagement! 🎥 Friends, I need your help by giving us a thumbs-up 👍! It will make a real impact by helping us secure funds for ongoing work empowering youth. Thank you!

https://t.co/YPmAayXKgV

[Mithu Maheswaranathan, MD @MithuRheum]

Latest in Lupus Treatment at #ACR23
• Dr. Dall’Era & Dr. Furie
• Approach to Lupus Nephritis 🫘
• Treating Non-Renal SLE / Skin

#Lupus #RheumTwitter #Rheumatology

[Erin Tree, DO @DrTinyTree]

1/4: New developments in pediatric #sjogrens disease at #ACR23 - Dr. Sara Stern on evaluation & management

DDX: 3 dx can occur concurrently
-lymphoma
-MALT lymphoma
-juvenile recurrent parotitis of childhood

Diagnostic algorithm for cSD
-4 pathways

#ACRambassador #pedsrheum

[Lupus Foundation of America @LupusOrg]

Get excited for #ACR23! Follow us Nov. 12-14 for the latest in #LupusResearch including #lupus treatment news at this year’s @ACRheum scientific conference.

[Paul Sufka, MD @psufka]

Takeaways from #ACR23 #ReviewCourse session on Transition of Care Concerns in JIA - Dr. Rebecca Sadun

1. Know the subtypes of JIA (see slide) because there are significant differences and considerations.
2. Be aware of TMJ in JIA, which can cause damage and symptoms throughout life, but also occasionally have active inflammation.
3. Also be aware of anterior uveitis in JIA. Often asymptomatic until vision loss occurs, so patients should have lifelong screening. (Lower risk over duration of disease)
4. Younger patients often have higher metabolism of medications, so often using high doses of MTX etc.
5. Over 50% of pediatric patients don't show up after their first adult visit (!!!), so TRANSFER and WELCOME mnemonics can be helpful (see slides)

[Michelle Rheault @rheault_m]

Yesterday was a really good day.

Maybe even a career high.

I should be popping the 🍾.

But with every high has to come a low, right? That’s how this works.

Have you been getting your mammograms like you’re supposed to?

I haven’t. 🧵
#KidneyWk
#WomenInMedicine

[Lupus Foundation of America @LupusOrg]

New study finds that inflammation in the developing central nervous systems of children with #lupus can negatively affect cognition, mood, academic performance, and overall quality of life. Read the study: https://t.co/O995B8QIfN

[Donald Thomas, MD @lupuscyclopedia]

🔥This is a fantastic article by @EricFMorand @TimothyNiewold and @ashira_md : well written about current #SLE #lupus treatments: https://t.co/8LK9vUGoP8

👉HOWEVER, I really love their introduction. Instead of the typical, boring, simplified, and not totally correct intro of "SLE is a systemic autoimmune disease of unknown etiology," they give a much better intro (all other research papers on SLE, take note:

✏️ "Patients classified as having systemic lupus erythematosus manifest immune-mediated inflammatory injury in virtually every organ system, and therefore, lupus can present across all fields of medicine. This well-known clinical heterogeneity results in many difficulties, including how to make the diagnosis or standardize treatment approaches. We now also know that patients clinically classified as having systemic lupus erythematosus represent a cluster of differing molecular pathologies that could explain these diverse phenotypes..."